Stock Research: Medicover

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Medicover

OM:MCOV B SE0009778848
37
  • Value
    10
  • Growth
    100
  • Safety
    Safety
    17
  • Combined
    22
  • Sentiment
    61
  • 360° View
    360° View
    37
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers healthcare services (primary care, specialist outpatient and inpatient care via clinics and medical facilities) and diagnostic services (laboratory testing for humans and some veterinary services). The company primarily operates in Poland, Germany, Romania, and Ukraine. In the last fiscal year, the company had a market cap of $4085 million, profits of $464 million, revenue of $2166 million, and 47256 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 37 (better than 37% compared with alternatives), overall professional sentiment and financial characteristics for the stock Medicover are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Medicover. The consolidated Growth Rank has a good rank of 100, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 100% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 61, which means that professional investors are more optimistic about the stock than for 61% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 17, which means that the share price of Medicover is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 83% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 10, which means that the company has a financing structure that is riskier than those of 90% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
Human Rights
SDG 13
SDG 16
SDG 3
SDG 4
SDG 8
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
17 34 28 29
Growth
100 98 100 87
Safety
Safety
10 9 14 42
Sentiment
61 42 42 41
360° View
360° View
37 39 41 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
49 51 41 43
Opinions Change
59 50 83 50
Pro Holdings
n/a 24 4 30
Market Pulse
64 49 59 56
Sentiment
61 42 42 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
17 34 28 29
Growth
100 98 100 87
Safety Safety
10 9 14 42
Combined
22 34 41 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
12 17 10 13
Price vs. Earnings (P/E)
71 75 73 64
Price vs. Book (P/B)
9 16 22 18
Dividend Yield
37 45 47 48
Value
17 34 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
88 85 94 84
Profit Growth
92 88 71 96
Capital Growth
91 68 93 6
Stock Returns
91 90 57 97
Growth
100 98 100 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
4 5 16 46
Refinancing
19 16 15 37
Liquidity
20 24 24 30
Safety Safety
10 9 14 42

Similar Stocks

Discover high‑ranked alternatives to Medicover and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

SKF

OM:SKF B
Country: Sweden
Industry: Industrial Machinery
Size: Large
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Infineon

XTRA:IFX
Country: Germany
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.